DALLAS, June 26, 2012 /PRNewswire/ -- Goldfarb LLP is investigating whether the board of directors of American Oriental Bioengineering, Inc. (OTC: AOBI) violated shareholder protection laws as evidenced through alleged inconsistencies in the company's financial statements. Concerned AOBI investors who purchased stock before June 15, 2012 are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or email@example.com about their rights and remedies.
"On March 16, 2012, auditor Ernst & Young informed the company's audit committee of discrepancies in the company's financial statements for fiscal year 2011. As a result, trading halted, the stock was delisted, and shares fell almost 60%," securities lawyer Hamilton Lindley said. "Our proposed shareholder lawsuit will seek to ensure that proper controls are placed to ensure accurate financial reporting, to correct any improper behavior, and to improve the company's value for investors."
Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. American Oriental Bioengineering, Inc. shareholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-583-2855.
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
|SOURCE Goldfarb LLP|
Copyright©2012 PR Newswire.
All rights reserved